CAS 103765-01-1
:UCB-L 060
Description:
UCB-L 060, with the CAS number 103765-01-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule and is known for its role as a selective antagonist of certain receptors, which may contribute to its pharmacological effects. The compound exhibits a specific binding affinity, making it a candidate for research in areas such as neuropharmacology and inflammation. Its chemical structure includes functional groups that enhance its bioactivity and solubility, which are critical for its efficacy in biological systems. UCB-L 060 has been studied in various preclinical models to evaluate its safety profile and therapeutic potential. As with many compounds in drug development, ongoing research aims to elucidate its mechanism of action, optimize its pharmacokinetic properties, and assess its overall impact on targeted biological pathways.
Formula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m1/s1
InChI key:InChIKey=HPHUVLMMVZITSG-ZCFIWIBFSA-N
SMILES:[C@H](C(N)=O)(CC)N1C(=O)CCC1
Synonyms:- (2R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-Etiracetam
- (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide,a-ethyl-2-oxo-, (R)-
- Ucb-L 060
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
LEVETIRACETAM IMPURITY D CRS
CAS:<p>LEVETIRACETAM IMPURITY D CRS</p>Formula:C8H14N2O2Molecular weight:170.209(αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
CAS:Formula:C8H14N2O2Purity:98%Color and Shape:SolidMolecular weight:170.2090Levetiracetam EP Impurity D ((R)-Levetiracetam)
CAS:Formula:C8H14N2O2Color and Shape:White To Off-White SolidMolecular weight:170.21(R)-Levetiracetam
CAS:Controlled Product<p>Impurity Levetiracetam EP Impurity D<br>Applications (R)-Levetiracetam [REV] (Levetiracetam EP Impurity D), is the enantiomer to Levetiracetam [LEV] (L331500), the antiepileptic drug that is highly enantioselective. It is apparent that [LEV] is more potent than [REV] in terms of antiepileptic potency.<br>References Isoherranen, N. et al.: Epilepsia, 42, 825 (2001); Isoherranen, N. et al.: Epilepsia, 44, 1280 (2003);<br></p>Formula:C8H14N2O2Color and Shape:NeatMolecular weight:170.21(R)-Levetiracetam
CAS:Controlled Product<p>Levetiracetam is an antiepileptic drug that belongs to the class of drugs known as pyrrolidone derivatives. It is approved for the treatment of partial seizures, myoclonic seizures, and generalized tonic-clonic seizures. Levetiracetam binds to synaptic vesicle protein 2A at the same site as levetiracetam and prevents the release of neurotransmitters from nerve cells. This binding leads to neuronal death by inhibiting mitochondrial functions and reducing neuronal excitability by blocking voltage-sensitive sodium channels. Levetiracetam has been shown to have a concentration-time curve that is similar to intravenous anaesthetics in animal models. This drug also has a polymerase chain reaction (PCR) assay that can detect whether levetiracetam is present in urine samples; this test can be used as an aid in forensic investigations.</p>Formula:C8H14N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:170.21 g/mol






